Joel Greenblatt Roivant Sciences Ltd. Transaction History
Gotham Asset Management, LLC
- $21.9 Billion
- Q3 2025
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 330,475 shares of ROIV stock, worth $6.71 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
330,475
Previous 39,149
744.15%
Holding current value
$6.71 Million
Previous $441,000
1033.79%
% of portfolio
0.02%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ROIV
# of Institutions
363Shares Held
463MCall Options Held
6.49MPut Options Held
1.78M-
Morgan Stanley New York, NY44.3MShares$899 Million0.04% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X040.3MShares$818 Million4.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA38.8MShares$787 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$718 Million0.01% of portfolio
-
Qvt Financial LP New York, NY29.4MShares$596 Million36.4% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $14.3B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...